{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:57:37Z","timestamp":1793901457722,"version":"4.8.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Mevalonate kinase deficiency (MKD), a rare auto-inflammatory disorder, arises from mutations in the\n                    <jats:italic>MVK<\/jats:italic>\n                    gene, disrupting isoprenoid biosynthesis, and affecting cellular processes. This comprehensive review provides an updated perspective on MKD, including its aetiology, pathogenesis, diagnostic modalities, and therapeutic strategies. Based on recent research and clinical advances, our objective is to bridge the knowledge gaps in the 2015 SHARE guidelines. By describing molecular mechanisms, diagnostic dilemmas, and emerging therapies, this article should serve as a resource for clinicians and researchers, promoting a deeper understanding of MKD and guiding optimal patient care.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2024.1466844","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:44:21Z","timestamp":1731401061000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations"],"prefix":"10.3389","volume":"15","author":[{"given":"Lilla","family":"Lengv\u00e1ri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kata","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"P\u00e1link\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine Helena","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kon\u00e9-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold","family":"Jeyaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Jane","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Uziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rton","family":"Szabados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","article-title":"Mevalonate kinase deficiency, a metabolic autoinflammatory disease","volume":"147","author":"van der Burgh","year":"2013","journal-title":"Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2180-8","article-title":"Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children","volume":"32","author":"Lainka","year":"2012","journal-title":"Rheumatol Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-8-29","article-title":"Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey","volume":"8","author":"Toplak","year":"2010","journal-title":"Pediatr Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","article-title":"Natural history of mevalonate kinase deficiency: a literature review","volume":"14","author":"Zhang","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237999","article-title":"Spectrum of clinical features and genetic variants in mevalonate kinase (MVK) gene of South Indian families suffering from Hyperimmunoglobulin D Syndrome","volume":"15","author":"Govindaraj","year":"2020","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1442639","article-title":"National survey of Japanese patients with mevalonate kinase deficiency reveals distinctive genetic and clinical characteristics","volume":"29","author":"Tanaka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-98605-0_17","article-title":"Mevalonate Kinase Deficiency in Hashkes PJ et al. (eds)","volume-title":"Textbook of Autoinflammation.","author":"Frenkel","year":"2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","article-title":"A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry","volume":"12","author":"Papa","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.ejhg.5200933","article-title":"Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands","volume":"11","author":"Houten","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12126","article-title":"In silico prediction of the effects of mutations in the human mevalonate kinase gene: towards a predictive framework for mevalonate kinase deficiency","volume":"79","author":"Browne","year":"2015","journal-title":"Ann Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.25.3115","article-title":"Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in Hyper-IgD and periodic fever syndrome","volume":"11","author":"Houten","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/715465","article-title":"Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study","volume":"2013","author":"Tricarico","year":"2013","journal-title":"BioMed Res Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3890-3","article-title":"MMAB, a novel candidate gene to be screened in the molecular diagnosis of Mevalonate Kinase Deficiency","volume":"38","author":"Mezzavilla","year":"2018","journal-title":"Rheumatol Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2015_489","article-title":"Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency","volume":"27","author":"Jeyaratnam","year":"2016","journal-title":"JIMD Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2577-z","article-title":"Mevalonate kinase genotype in children with recurrent fevers and high serum IgD level","volume":"33","author":"Stabile","year":"2013","journal-title":"Rheumatol Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12412","article-title":"Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria","volume":"44","author":"Brennenstuhl","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.005","article-title":"AA amyloidosis revealing mevalonate kinase deficiency: A report of 20 cases including two new French cases and a comprehensive review of literature","volume":"50","author":"Rodrigues","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.723","article-title":"Second-hit somatic mutations in mevalonate pathway genes underlie porokeratosis","volume":"139","author":"Atzmony","year":"2019","journal-title":"J Investig Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/13816810.2016.1227459","article-title":"Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations","volume":"38","author":"Kellner","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: A series of 114 cases from the eurofever registry","volume":"68","author":"ter Haar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.jid.2019.05.020","article-title":"Clonal expansion of second-hit cells with somatic recombinations or C>T transitions form porokeratosis in MVD or MVK mutant heterozygotes","volume":"139","author":"Kubo","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7554\/elife.06322","article-title":"Genomic variations of the mevalonate pathway in porokeratosis","volume":"4","author":"Zhang","year":"2015","journal-title":"eLife"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081552","article-title":"Mevalonate kinase-associated diseases: hunting for phenotype-genotype correlation","volume":"10","author":"Boursier","year":"2021","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213524","article-title":"Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency","volume":"77","author":"Carapito","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3115-y","article-title":"GRID2 a novel gene possibly associated with mevalonate kinase deficiency","volume":"35","author":"Moura","year":"2015","journal-title":"Rheumatol Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab139","article-title":"Mevalonate kinase deficiency: A cause of severe very-early-onset inflammatory bowel disease","volume":"27","author":"Bader-Meunier","year":"2021","journal-title":"Inflammation Bowel Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306555","article-title":"Mevalonate kinase deficiency and IBD: shared genetic background","volume":"63","author":"Bianco","year":"2014","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/prs.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/13506120500106982","article-title":"Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome","volume":"12","author":"van der Hilst","year":"2005","journal-title":"Amyloid"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06457-9","article-title":"High serum immunoglobulin D levels in systemic lupus erythematosus: more to be found","volume":"42","author":"Liang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-135-5-200109040-00010","article-title":"Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igD and periodic fever syndrome: its application as a diagnostic tool","volume":"135","author":"Simon","year":"2001","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01359.x","article-title":"Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response","volume":"256","author":"Simon","year":"2004","journal-title":"J Intern Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/bf00918854","article-title":"Immunological studies in the hyper-immunoglobulin D syndrome","volume":"12","author":"Haraldsson","year":"1992","journal-title":"J Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1128\/cdli.8.1.58-61.2001","article-title":"Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome","volume":"8","author":"Klasen","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2015.05.007","article-title":"Quantification of mevalonate-5-phosphate using UPLC-MS\/MS for determination of mevalonate kinase activity","volume":"48","author":"Reitzle","year":"2015","journal-title":"Clin Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jaci.2017.02.033","article-title":"Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency","volume":"140","author":"Munoz","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.58","article-title":"Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases","volume":"94","author":"Jurczyluk","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01900","article-title":"Defective protein prenylation in a spectrum of patients with mevalonate kinase deficiency","volume":"10","author":"Munoz","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/art.23474","article-title":"A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-11-5","article-title":"Time to share","volume":"11","author":"Wulffraat","year":"2013","journal-title":"Pediatr Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/annrheumdis-2014-206580","article-title":"Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers","volume":"74","author":"Federici","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12969-020-0409-3","article-title":"Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD\/HIDS: a German PRO-KIND initiative","volume":"18","author":"Hansmann","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221801","article-title":"The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist","volume":"81","author":"Romano","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.15722","article-title":"Making a diagnosis of periodic fever syndrome: Experience from a single tertiary centre","volume":"58","author":"McNaughton","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa031","article-title":"Validation of the new classification criteria for hereditary recurrent fever in an independent cohort: experience from the JIR Cohort Database","volume":"59","author":"Dingulu","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06557-0","article-title":"The assessment of autoinflammatory disease classification criteria (Eurofever\/PRINTO) in a real-life cohort","volume":"42","author":"\u00c7a\u011flayan","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B53","unstructured":"Infevers"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.18023","article-title":"Novel presentations of periodic fever syndromes: Discrepancies between genetic and clinical diagnoses","volume":"6","author":"Hoang","year":"2019","journal-title":"Eur J Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/annrheumdis-2011-201271","article-title":"Guidelines for the genetic diagnosis of hereditary recurrent fevers","volume":"71","author":"Shinar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa024","article-title":"ISSAID\/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era","volume":"66","author":"Shinar","year":"2020","journal-title":"Clin Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.berh.2017.12.001","article-title":"Periodic fever syndromes","volume":"31","author":"Lachmann","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152024","article-title":"Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)","volume":"55","author":"Sutera","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez270","article-title":"Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers","volume":"59","author":"Papa","year":"2020","journal-title":"Rheumatology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1257045","article-title":"Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study","volume":"10","author":"Alexeeva","year":"2023","journal-title":"Front Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkz004","article-title":"Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review","volume":"3","author":"Garg","year":"2019","journal-title":"Rheumatol Adv Pr"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108697","article-title":"Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature","volume":"226","author":"Luu","year":"2021","journal-title":"Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.908501","article-title":"Development and implementation of the AIDA international registry for patients with undifferentiated systemic autoInflammatory diseases","volume":"9","author":"Casa","year":"2022","journal-title":"Front Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-015-2505-9","article-title":"Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience","volume":"174","author":"Kostjukovits","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170684","article-title":"Efficacy of continuous interleukin 1 blockade in mevalonate kinase deficiency: A multicenter retrospective study in 13 adult patients and literature review","volume":"45","author":"Deshayes","year":"2018","journal-title":"J Rheumatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac041","article-title":"Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marketing surveillance in Japan","volume":"33","author":"Hosono","year":"2023","journal-title":"Mod Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12969-021-00605-2","article-title":"Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States","volume":"19","author":"Hur","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2020.02.001","article-title":"Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases","volume":"62","author":"\u00c7akan","year":"2020","journal-title":"Turk J Pediatr"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab696","article-title":"Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial","volume":"61","author":"Jeyaratnam","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/e92f7o","article-title":"Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial","author":"Lachmann","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-020-1892-9","article-title":"Growth parameters of turkish children with an autoinflammatory disease before and after canakinumab treatment","volume":"57","author":"Balci","year":"2020","journal-title":"Indian Pediatr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23120","article-title":"International retrospective chart review of treatment patterns in severe familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000442576.41537.de","article-title":"Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"bcr2015210513","DOI":"10.1136\/bcr-2015-210513","article-title":"Anti-interleukin 6 receptor therapy for hyper-IgD syndrome","author":"Musters","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1542\/peds.91.5.915","article-title":"Clinical and biochemical phenotype in 11 patients with mevalonic aciduria","volume":"91","author":"Hoffmann","year":"1993","journal-title":"Pediatrics"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1159\/000518825","article-title":"An atypical presentation of mevalonate kinase deficiency in response to colchicine treatment","volume":"13","author":"Yeked\u00fcz","year":"2022","journal-title":"Mol Syndromol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-196","article-title":"Weekly oral alendronate in mevalonate kinase deficiency","volume":"8","author":"Cantarini","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3957","article-title":"Alendronate, a double-edged sword acting in the mevalonate pathway","volume":"12","author":"Tricarico","year":"2015","journal-title":"Mol Med Rep"},{"key":"B82","first-page":"88","article-title":"Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever","volume":"42","author":"G\u00f6k","year":"2017","journal-title":"Acta Reum Port"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04490-7","article-title":"Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review","volume":"40","author":"Karadeniz","year":"2020","journal-title":"Rheumatol Int"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key384","article-title":"Tofacitinib for familial Mediterranean fever: a new alternative therapy","volume":"58","author":"Garcia-Robledo","year":"2019","journal-title":"Rheumatology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa070715","article-title":"Allogeneic bone marrow transplantation in mevalonic aciduria","volume":"356","author":"Neven","year":"2007","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1038\/s41598-023-32671-9","article-title":"CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure","volume":"13","author":"Lambros","year":"2023","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3456-9","article-title":"Massive ascites in a canakinumab resistant case with MVA leading to bone marrow transplantation","volume":"36","author":"Erdol","year":"2016","journal-title":"Rheumatol Int"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc072018","article-title":"Mevalonic aciduria cured by bone marrow transplantation","volume":"357","author":"Arkwright","year":"2007","journal-title":"N Engl J Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa912","article-title":"Haploidentical \u03b1\/\u03b2 T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency","volume":"60","author":"Faraci","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-022-00716-4","article-title":"The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency","volume":"20","author":"Jeyaratnam","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203666","article-title":"Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes","volume":"73","author":"Piram","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105448","article-title":"Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab","volume":"89","author":"Kon\u00e9-Paut","year":"2022","journal-title":"Joint Bone Spine"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210092","article-title":"Development of the autoinflammatory disease damage index (ADDI)","volume":"76","author":"ter Haar","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213725","article-title":"In silico validation of the Autoinflammatory Disease Damage Index","volume":"77","author":"ter Haar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B95","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth J Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144741","article-title":"Autoinflammatory diseases and COVID-19 vaccination: analysis of SARS-coV-2 anti-S-RBD igG levels in a cohort of patients receiving IL-1 inhibitors","volume":"12","author":"Bindoli","year":"2023","journal-title":"J Clin Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2022.04.006","article-title":"Neurological manifestations in mevalonate kinase deficiency: A systematic review","volume":"136","author":"Elhani","year":"2022","journal-title":"Mol Genet Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/md.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105490","article-title":"A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation","volume":"90","author":"Y\u0131ld\u0131z","year":"2023","journal-title":"Joint Bone Spine"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.06.013","article-title":"Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases","volume":"152","author":"Berner","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14451","article-title":"A novel homozygous variant in PMVK is associated with enhanced IL1\u03b2 secretion and a hyper-IgD syndrome-like phenotype","volume":"105","author":"Jairaman","year":"2024","journal-title":"Clin Genet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/srep24226","article-title":"Loss-of-function mutation in PMVK causes autosomal dominant disseminated superficial porokeratosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06384-9","article-title":"Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review","volume":"42","author":"Y\u0131ld\u0131r\u0131m","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2923-0","article-title":"Macrophage activation syndrome in the course of monogenic autoinflammatory disorders","volume":"34","author":"Rigante","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/art.22409","article-title":"First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome","volume":"56","author":"Rigante","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: A survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3487","article-title":"Control of the innate immune response by the mevalonate pathway","volume":"17","author":"Akula","year":"2016","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1466844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:44:28Z","timestamp":1731401068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1466844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2024.1466844"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1466844","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"article-number":"1466844"}}